🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to find out if SU011248 works and if it is saf...
Status
Completed
Location
Tom Baker Cancer Centre
Start Date
2008-04
Trial ID
NCT00578526
To compare treatment with SU011248 plus paclitaxel versus bevacizumab plus ...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2006-11
Trial ID
NCT00373256
Treatments Being Tested
The purpose is to determine the safety, effectiveness and best dose to use ...
Status
Completed
Location
City Of Hope
Start Date
2012-02-09
Trial ID
NCT01472081
Treatments Being Tested
This is a phase 3 randomized trial evaluating the anti-tumor activity and s...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2007-02
Trial ID
NCT00393939
Treatments Being Tested
the primary objective of this study is to assess the efficacy (progression-...
Status
Completed
Location
Beijing Cancer Hospital
Start Date
2020-11-25
Trial ID
NCT04633122
Treatments Being Tested
This trial will be conducted to evaluate the efficacy, safety, and tolerabi...
Status
Completed
Location
Universität Heidelberg, Nationales Zentrum für Tumorerkrankungen
Start Date
2006-12
Trial ID
NCT00411151
Treatments Being Tested
The aim of this study is to evaluate the safety and efficacy of lenvatinib ...
Status
Recruiting
Location
Asan Medical Center
Start Date
2025-10-29
Trial ID
NCT07096609
Treatments Being Tested
A randomized, open, two-period, two-sequence crossover trial design used to...
Status
Completed
Location
Affiliated Hospital of Changchun University of Traditional Chinese Medicine
Start Date
2018-12-04
Trial ID
NCT05800106
Treatments Being Tested
This study will test whether treatment with erlotinib plus SU011248 is bett...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2007-07
Trial ID
NCT00457392
This phase 1/2a trial is conducted in Europe. The first part of the trial i...
Status
Completed
Location
Novo Nordisk Investigational Site
Start Date
2007-07-12
Trial ID
NCT00617253